Prostate MRI Biomarker Study for Prostate Cancer
EDRN Prostate MRI Biomarker Study
Recruiting
Observational Study
PSA
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 950 (estimated)
- Sponsor
- University of Michigan · Other
Who this trial is looking for
This trial is looking for men who might have prostate cancer and are scheduled for a biopsy. Participants will help researchers find out if MRI scans are better than certain lab tests for detecting cancer during the initial biopsy.
Are You a Good Fit for This Trial?
You may be able to join if
- I have suspected but undiagnosed prostate cancer
- I am scheduled for a biopsy
You may not be able to join if
- I cannot provide blood and urine samples
- I cannot tolerate a prostate MRI
- I have been diagnosed with prostate cancer before
- I have had a prostate MRI unless it was done within the last year
- I am participating in another clinical trial for prostate disease
- I have had prostate surgery like TURP or TUNA
- I have had tests like PCA3 or TMPRSS2:ERG for clinical purposes
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This study will allow investigators to determine if prostate MRI is superior to validated panel of laboratory biomarkers (e.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men with suspected but undiagnosed prostate cancer
* To be scheduled/scheduled for biopsy as routine clinical care
Exclusion Criteria:
* Inability to obtain blood and urine per SOP or conduct an attentive DRE
* Unable to undergo/tolerate a prostate MRI or failure to conduct …
Contacts